Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Dr. Iman JeddiSenior VP & GM of da Vinci Platforms & Product Operations | -5,63k | 1,93M | Derivative Exercise and Sale | 77,00 - 420,55 | 33,11k | - |
| 2026-05-21 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -36,00 | 15,95k | Automatic Disposition | 439,80 - 446,04 | 1,52k | -2,31% |
| 2026-05-18 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -54,00 | 23,46k | Automatic Disposition | 422,47 - 440,70 | 1,56k | -3,35% |
| 2026-05-11 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | -400,00 | 178,78k | Automatic Disposition | 446,95 | 6,12k | -6,13% |
| 2026-04-30 | Dr. Monica P. ReedIndependent Director | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 2,88k | 22,64% |
| 2026-04-30 | Ms. Jami K. Dover NachtsheimIndependent Director | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,90k | 8,33% |
| 2026-04-30 | Mr. Keith R. LeonardIndependent Director | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 901,00 | 143,51% |
| 2026-04-30 | Dr. Amy L. LaddIndependent Director | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 651,00 | 442,50% |
| 2026-04-30 | Ms. Sreelakshmi KolliIndependent Director | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,51k | 54,24% |
| 2026-04-30 | Ms. Amal M. JohnsonInsider | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 13,55k | 4,08% |
| 2026-04-30 | Mr. Lewis ChewIndependent Director | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,31k | 67,82% |
| 2026-04-30 | Mr. Joseph C. BeeryIndependent Director | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,64k | 17,07% |
| 2026-04-30 | Dr. Craig H. BarrattLead Independent Director | 750,00 | 0,00 | Derivative Exercise and Retained Stock | - | 27,95k | 2,76% |
| 2026-04-28 | Dr. Amy L. LaddIndependent Director | -619,00 | 291,89k | Automatic Disposition | 463,50 - 473,46 | 120,00 | -83,76% |
| 2026-03-10 | Dr. Myriam J. Curet McAdamsInsider | -105,00 | 27,78k | Derivative Exercise and Sale | 229,39 - 493,95 | 409,00 | - |
| 2026-03-06 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -1,29k | 630,47k | Automatic Disposition | 485,01 - 490,19 | 1,61k | -44,49% |
| 2026-03-03 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -3,66k | 1,82M | Automatic Disposition | 488,10 - 498,68 | 2,91k | -55,73% |
| 2026-02-28 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | 117,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,03k | 12,87% |
| 2026-02-28 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | -351,00 | 174,81k | Derivative Exercise and Sale | 487,18 - 503,51 | 1,03k | - |
| 2026-02-27 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | -249,00 | 124,43k | Automatic Disposition | 499,71 | 1,03k | -19,53% |
| 2026-03-02 | Dr. Myriam J. Curet McAdamsInsider | -125,00 | 35,46k | Derivative Exercise and Sale | 208,90 - 492,59 | 409,00 | - |
| 2026-03-03 | Dr. Myriam J. Curet McAdamsInsider | -4,73k | 2,30M | Automatic Disposition | 487,18 | 409,00 | -92,04% |
| 2026-02-28 | Dr. Iman JeddiSenior VP & GM of da Vinci Platforms & Product Operations | 4,54k | 0,00 | Derivative Exercise and Retained Stock | - | 33,11k | 15,88% |
| 2026-02-28 | Dr. Iman JeddiSenior VP & GM of da Vinci Platforms & Product Operations | -4,47k | 2,25M | Derivative Exercise and Sale | 503,51 | 33,11k | - |
| 2026-02-28 | Dr. Gary S. GuthartExecutive Chair | 14,54k | 0,00 | Derivative Exercise and Retained Stock | - | 1,29M | 1,14% |
| 2026-02-28 | Dr. Gary S. GuthartExecutive Chair | -14,30k | 7,20M | Derivative Exercise and Sale | 503,51 | 1,29M | - |
| 2026-02-28 | Mr. Jamie E. SamathExec. VP, CFO & Enterprise Technology Leader | 5,81k | 0,00 | Derivative Exercise and Retained Stock | - | 15,37k | 60,78% |
| 2026-02-28 | Mr. Jamie E. SamathExec. VP, CFO & Enterprise Technology Leader | -5,72k | 2,88M | Derivative Exercise and Sale | 503,51 | 15,37k | - |
| 2026-02-28 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | 1,59k | 0,00 | Derivative Exercise and Retained Stock | - | 6,52k | 32,14% |
| 2026-02-28 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | -1,56k | 786,48k | Derivative Exercise and Sale | 503,51 | 6,52k | - |
| 2026-02-28 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | 6,39k | 0,00 | Derivative Exercise and Retained Stock | - | 11,61k | 122,41% |
| 2026-02-28 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | -5,14k | 2,59M | Derivative Exercise and Sale | 503,51 | 11,61k | - |
| 2026-02-28 | Mr. David J. RosaCEO & Director | 12,56k | 0,00 | Derivative Exercise and Retained Stock | - | 245,21k | 5,40% |
| 2026-02-28 | Mr. David J. RosaCEO & Director | -12,36k | 6,22M | Derivative Exercise and Sale | 503,51 | 245,21k | - |
| 2026-02-28 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | 4,67k | 0,00 | Derivative Exercise and Retained Stock | - | 6,56k | 245,66% |
| 2026-02-28 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -4,59k | 2,31M | Derivative Exercise and Sale | 503,51 | 6,56k | - |
| 2026-02-28 | Dr. Myriam J. Curet McAdamsInsider | 4,73k | 0,00 | Derivative Exercise and Retained Stock | - | 5,14k | 1.155,99% |
| 2026-02-28 | Dr. Myriam J. Curet McAdamsInsider | -4,65k | 2,34M | Derivative Exercise and Sale | 503,51 | 5,14k | - |
| 2026-02-27 | Dr. Myriam J. Curet McAdamsInsider | -2,35k | 1,17M | Automatic Disposition | 499,71 | 5,14k | -31,34% |
| 2026-02-26 | Ms. Patricia L. WadorsSenior VP & Chief HR Officer | -458,00 | 230,40k | Derivative Exercise and Sale | 499,71 - 506,17 | 0,00 | - |
| 2026-02-26 | Dr. Iman JeddiSenior VP & GM of da Vinci Platforms & Product Operations | 1,34k | 0,00 | Derivative Exercise and Retained Stock | - | 28,57k | 4,91% |
| 2026-02-26 | Dr. Iman JeddiSenior VP & GM of da Vinci Platforms & Product Operations | -972,00 | 492,00k | Derivative Exercise and Sale | 506,17 | 28,57k | - |
| 2026-02-26 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | 1,52k | 0,00 | Derivative Exercise and Retained Stock | - | 5,22k | 41,20% |
| 2026-02-26 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | -1,22k | 619,55k | Derivative Exercise and Sale | 506,17 | 5,22k | - |
| 2026-02-26 | Mr. Jamie E. SamathExec. VP, CFO & Enterprise Technology Leader | 1,76k | 0,00 | Derivative Exercise and Retained Stock | - | 9,56k | 22,54% |
| 2026-02-26 | Mr. Jamie E. SamathExec. VP, CFO & Enterprise Technology Leader | -1,64k | 829,11k | Derivative Exercise and Sale | 506,17 | 9,56k | - |
| 2026-02-26 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | 1,23k | 0,00 | Derivative Exercise and Retained Stock | - | 4,93k | 33,21% |
| 2026-02-26 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | -1,21k | 613,48k | Derivative Exercise and Sale | 506,17 | 4,93k | - |
| 2026-02-26 | Dr. Myriam J. Curet McAdamsInsider | 2,35k | 0,00 | Derivative Exercise and Retained Stock | - | 2,75k | 573,35% |
| 2026-02-26 | Dr. Myriam J. Curet McAdamsInsider | -2,31k | 1,17M | Derivative Exercise and Sale | 506,17 | 2,75k | - |
| 2026-02-26 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | 498,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,16k | 75,45% |
| 2026-02-26 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | -491,00 | 248,53k | Derivative Exercise and Sale | 506,17 | 1,16k | - |
| 2026-02-26 | Mr. David J. RosaCEO & Director | 3,08k | 0,00 | Derivative Exercise and Retained Stock | - | 232,65k | 1,34% |
| 2026-02-26 | Mr. David J. RosaCEO & Director | -3,03k | 1,53M | Derivative Exercise and Sale | 506,17 | 232,65k | - |
| 2026-02-26 | Dr. Gary S. GuthartExecutive Chair | 4,23k | 0,00 | Derivative Exercise and Retained Stock | - | 1,27M | 0,33% |
| 2026-02-26 | Dr. Gary S. GuthartExecutive Chair | -4,16k | 2,11M | Derivative Exercise and Sale | 506,17 | 1,27M | - |
| 2026-02-26 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | 1,31k | 0,00 | Derivative Exercise and Retained Stock | - | 1,90k | 220,78% |
| 2026-02-26 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -1,29k | 651,95k | Derivative Exercise and Sale | 506,17 | 1,90k | - |
| 2026-02-10 | Dr. Myriam J. Curet McAdamsInsider | -943,00 | 441,74k | Derivative Exercise and Sale | 229,39 - 494,96 | 409,00 | - |
| 2026-02-10 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | 132,00 | 0,00 | Derivative Exercise and Retained Stock | - | 660,00 | 25,00% |
| 2026-02-10 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | -435,00 | 214,67k | Derivative Exercise and Sale | 492,84 - 494,96 | 660,00 | - |
| 2026-02-10 | Mr. David J. RosaCEO & Director | 712,00 | 0,00 | Derivative Exercise and Retained Stock | - | 229,57k | 0,31% |
| 2026-02-10 | Mr. David J. RosaCEO & Director | -724,00 | 356,82k | Derivative Exercise and Sale | 492,84 | 229,57k | - |
| 2026-02-10 | Dr. Gary S. GuthartExecutive Chair | 1,33k | 0,00 | Derivative Exercise and Retained Stock | - | 1,27M | 0,10% |
| 2026-02-10 | Dr. Gary S. GuthartExecutive Chair | -1,31k | 643,65k | Derivative Exercise and Sale | 492,84 | 1,27M | - |
| 2026-02-10 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | 143,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,70k | 4,02% |
| 2026-02-10 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | -172,00 | 84,77k | Derivative Exercise and Sale | 492,84 | 3,70k | - |
| 2026-02-10 | Dr. Iman JeddiSenior VP & GM of da Vinci Platforms & Product Operations | 529,00 | 0,00 | Derivative Exercise and Retained Stock | - | 27,23k | 1,98% |
| 2026-02-10 | Dr. Iman JeddiSenior VP & GM of da Vinci Platforms & Product Operations | -309,00 | 152,29k | Derivative Exercise and Sale | 492,84 | 27,23k | - |
| 2026-02-10 | Mr. Jamie E. SamathExec. VP, CFO & Enterprise Technology Leader | 581,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,80k | 8,05% |
| 2026-02-10 | Mr. Jamie E. SamathExec. VP, CFO & Enterprise Technology Leader | -496,00 | 244,45k | Derivative Exercise and Sale | 492,84 | 7,80k | - |
| 2026-02-10 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | 585,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,70k | 18,80% |
| 2026-02-10 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | -492,00 | 242,48k | Derivative Exercise and Sale | 492,84 | 3,70k | - |
| 2026-02-10 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | 405,00 | 0,00 | Derivative Exercise and Retained Stock | - | 592,00 | 216,58% |
| 2026-02-10 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -433,00 | 213,40k | Derivative Exercise and Sale | 492,84 | 592,00 | - |
| 2026-01-29 | Mr. Keith R. LeonardIndependent Director | -369,00 | 0,00 | Other Disposition | - | 370,00 | -49,93% |
| 2026-01-29 | Dr. Myriam J. Curet McAdamsInsider | -126,00 | 39,20k | Derivative Exercise and Sale | 208,90 - 520,02 | 353,00 | - |
| 2026-01-27 | Dr. Myriam J. Curet McAdamsInsider | -230,00 | 72,30k | Derivative Exercise and Sale | 208,90 - 532,61 | 353,00 | - |
| 2026-01-27 | Dr. Gary S. GuthartExecutive Chair | -25,50k | 9,08M | Derivative Exercise and Sale | 174,26 - 531,53 | 1,27M | - |
| 2026-01-27 | Dr. Gary S. GuthartExecutive Chair | -1,80k | 956,74k | Automatic Disposition | 531,52 - 531,53 | 1,27M | -0,14% |
| 2025-12-15 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -464,00 | 254,50k | Automatic Disposition | 548,49 | 131,00 | -77,98% |
| 2025-12-12 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -312,00 | 170,78k | Automatic Disposition | 547,36 | 595,00 | -34,40% |
| 2025-12-12 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -4,50k | 2,10M | Derivative Exercise and Sale | 79,64 - 547,36 | 595,00 | - |
| 2025-12-10 | Dr. Myriam J. Curet McAdamsInsider | -104,00 | 34,37k | Derivative Exercise and Sale | 229,39 - 559,90 | 353,00 | - |
| 2025-12-01 | Dr. Myriam J. Curet McAdamsInsider | -125,00 | 45,01k | Derivative Exercise and Sale | 208,90 - 568,99 | 353,00 | - |
| 2025-12-01 | Dr. Gary S. GuthartExecutive Chair | 2,69k | 375,87k | Derivative Exercise and Retained Stock | 139,52 | 1,27M | 0,21% |
| 2025-12-01 | Dr. Gary S. GuthartExecutive Chair | -22,81k | 9,84M | Derivative Exercise and Sale | 139,52 - 570,89 | 1,27M | - |
| 2025-11-12 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | -9,00k | 3,15M | Derivative Exercise and Sale | 177,99 - 580,00 | 3,06k | - |
| 2025-11-12 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | -4,73k | 2,74M | Automatic Disposition | 580,00 | 3,06k | -60,76% |
| 2025-11-12 | Dr. Craig H. BarrattLead Independent Director | -750,00 | 381,51k | Derivative Exercise and Sale | 71,32 - 580,00 | 27,20k | - |
| 2025-11-12 | Mr. Keith R. LeonardIndependent Director | -1,61k | 0,00 | Other Disposition | - | 739,00 | -68,49% |
| 2025-11-10 | Dr. Myriam J. Curet McAdamsInsider | -105,00 | 34,71k | Derivative Exercise and Sale | 229,39 - 560,00 | 353,00 | - |
| 2025-11-10 | Dr. Brian E. MillerInsider | -3,50k | 1,25M | Derivative Exercise and Sale | 208,90 - 575,00 | 5,76k | - |
| 2025-11-05 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | -2,07k | 980,48k | Derivative Exercise and Sale | 59,46 - 550,00 | 473,00 | - |
| 2025-11-03 | Mr. David J. RosaCEO & Director | -5,45k | 0,00 | Other Disposition | - | 228,80k | -2,33% |
| 2025-10-28 | Dr. Myriam J. Curet McAdamsInsider | -7,69k | 2,42M | Derivative Exercise and Sale | 208,90 - 548,43 | 353,00 | - |
| 2025-10-24 | Dr. Gary S. GuthartExecutive Chair | 4,40k | 481,74k | Derivative Exercise and Retained Stock | 109,49 | 1,27M | 0,35% |
| 2025-10-24 | Dr. Gary S. GuthartExecutive Chair | -31,60k | 13,84M | Derivative Exercise and Sale | 109,49 - 547,56 | 1,27M | - |
| 2025-10-24 | Dr. Craig H. BarrattLead Independent Director | -2,19k | 1,05M | Derivative Exercise and Sale | 71,32 - 548,01 | 27,20k | - |
| 2025-10-24 | Mr. David J. RosaCEO & Director | 2,50k | 199,09k | Derivative Exercise and Retained Stock | 79,64 | 234,26k | 1,08% |
| 2025-10-24 | Mr. David J. RosaCEO & Director | -24,50k | 11,46M | Derivative Exercise and Sale | 79,64 - 547,55 | 234,26k | - |
| 2025-10-10 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | 1,32k | 0,00 | Derivative Exercise and Retained Stock | - | 3,56k | 58,62% |
| 2025-10-10 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | -1,30k | 575,11k | Derivative Exercise and Sale | 443,76 | 3,56k | - |
| 2025-09-03 | Dr. Amy L. LaddIndependent Director | -671,00 | 305,59k | Automatic Disposition | 440,69 - 470,11 | 739,00 | -47,59% |
| 2025-08-29 | Dr. Gary S. GuthartExecutive Chair | 6,64k | 528,79k | Derivative Exercise and Retained Stock | 79,64 | 1,26M | 0,53% |
| 2025-08-29 | Dr. Gary S. GuthartExecutive Chair | -29,36k | 11,53M | Derivative Exercise and Sale | 79,64 - 472,49 | 1,26M | - |
| 2025-07-28 | Dr. Gary S. GuthartExecutive Chair | -7,89k | 3,47M | Derivative Exercise and Sale | 59,46 - 498,64 | 1,26M | - |
| 2025-07-28 | Dr. Gary S. GuthartExecutive Chair | -2,80k | 1,39M | Automatic Disposition | 495,23 - 495,24 | 1,26M | -0,22% |
| 2025-07-28 | Dr. Gary S. GuthartExecutive Chair | -10,50k | 0,00 | Other Disposition | - | 1,26M | -0,83% |
| 2025-07-25 | Dr. Myriam J. Curet McAdamsInsider | -4,50k | 1,13M | Derivative Exercise and Sale | 242,34 - 492,48 | 353,00 | - |
| 2025-06-10 | Mr. David J. RosaCEO & Director | 684,00 | 0,00 | Derivative Exercise and Retained Stock | - | 231,76k | 0,30% |
| 2025-06-10 | Mr. David J. RosaCEO & Director | -674,00 | 354,63k | Derivative Exercise and Sale | 526,15 | 231,76k | - |
| 2025-06-05 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -431,00 | 242,18k | Automatic Disposition | 560,70 - 563,11 | 907,00 | -32,21% |
| 2025-06-04 | Mr. David J. RosaCEO & Director | -851,00 | 0,00 | Other Disposition | - | 231,07k | -0,37% |
| 2025-06-02 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -645,00 | 355,14k | Automatic Disposition | 549,06 - 552,07 | 1,34k | -32,53% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
